Staphylococcus aureus biofilms: in vitro and in vivo studies

金黄色葡萄球菌生物膜:体外和体内研究

基本信息

  • 批准号:
    7320471
  • 负责人:
  • 金额:
    $ 37.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-06-01 至 2012-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Staphylococcus aureus is a gram positive, ubiquitous bacterial species, with the predominant reservoir in nature being humans. The increased use of implanted medical devices such as intramedullary rods, screws, plates, and artificial joints has provided a physiological niche for microbes to cause infections. While a number of bacterial species may cause microbial fouling of indwelling medical devices, S. aureus causes a majority of these infections, producing high chronicity, morbidity, and mortality. One of the important mechanisms by which S. aureus is able to cause persistent infections on indwelling medical devices is through colonizing and synthesizing a "slime" layer, termed the glycocalyx or biofilm. This layer prevents infection resolution by antimicrobial agents and host phagocytic cells. Once an implant is colonized and chronic infection ensues, the standard treatment option is implant removal. This proposal seeks to identify S. aureus gene products with upregulated production in biofilms using two dimensional (2D) gel electrophoresis. Selected up-regulated proteins will then be evaluated, first, for their ability to be recognized by the host immune system during an in vivo biofilm infection, and second, for their protective efficacy in preventing infections in an implant-associated infection model in rabbits. The data generated here may contribute to the eventual development of a vaccine against S. aureus biofilms infections in humans. In addition, this proposal will also contribute to a more complete understanding of the bacterial factors involved in S. aureus biofilm formation and maturation. This understanding will enable one to create novel materials, surfaces, and/or disinfection strategies that resist or eliminate staphylococcal fouling and biofilm formation. Also, the proteome will be compared to transcriptome DMA microarray studies already completed in the Pi's laboratory in order to determine the global interrelation between gene expression and protein production for S. aureus biofilms grown under flow, thereby allowing staphylococci to be understood at a new level. Lastly, the results obtained in the evaluation of S. aureus biofilm formation may be used as a model for the biofilm formation by other closely related gram positive bacterial species, including Streptococcus spp., Listeria spp., Clostridium spp. and Bacillus spp.
描述(由申请方提供):金黄色葡萄球菌是一种革兰氏阳性、普遍存在的细菌菌种,自然界中的主要宿主是人类。越来越多地使用植入式医疗器械,如髓内杆、螺钉、板和人工关节,为微生物提供了引起感染的生理生态位。虽然许多细菌物种可能会导致留置医疗器械的微生物污染,但S。金黄色葡萄球菌引起大多数这些感染,产生高慢性、发病率和死亡率。S.金黄色葡萄球菌能够通过定殖和合成称为糖萼或生物膜的“粘液”层而在留置医疗装置上引起持续感染。该层防止抗微生物剂和宿主吞噬细胞的感染消退。一旦种植体定植并形成慢性感染,标准治疗选择是取出种植体。该建议旨在确定S。使用二维(2D)凝胶电泳检测在生物膜中具有上调产量的金黄色葡萄球菌基因产物。然后将首先评估所选择的上调蛋白在体内生物膜感染期间被宿主免疫系统识别的能力,其次评估其在兔的植入物相关感染模型中预防感染的保护功效。这里产生的数据可能有助于最终开发针对S.金黄色葡萄球菌生物膜感染人类。此外,这一建议也将有助于更全面地了解参与S.金黄色葡萄球菌生物膜形成和成熟。这种理解将使人们能够创造新的材料,表面和/或消毒策略,抵抗或消除葡萄球菌污垢和生物膜形成。此外,蛋白质组将与Pi实验室已经完成的转录组DMA微阵列研究进行比较,以确定S.金黄色葡萄球菌生物膜在流动下生长,从而使葡萄球菌被理解在一个新的水平。最后,对S.金黄色葡萄球菌生物膜形成可用作其它密切相关的革兰氏阳性细菌物种,包括链球菌属,李斯特菌属,梭菌属和芽孢杆菌属(Bacillus spp.)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(4)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mark E Shirtliff其他文献

Mark E Shirtliff的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mark E Shirtliff', 18)}}的其他基金

Staphylococcus aureus biofilms: in vitro and in vivo studies
金黄色葡萄球菌生物膜:体外和体内研究
  • 批准号:
    8116811
  • 财政年份:
    2010
  • 资助金额:
    $ 37.13万
  • 项目类别:
Staphylococcus aureus biofilms: in vitro and in vivo studies
金黄色葡萄球菌生物膜:体外和体内研究
  • 批准号:
    7618784
  • 财政年份:
    2007
  • 资助金额:
    $ 37.13万
  • 项目类别:
Staphylococcus aureus biofilms: in vitro and in vivo studies
金黄色葡萄球菌生物膜:体外和体内研究
  • 批准号:
    7890454
  • 财政年份:
    2007
  • 资助金额:
    $ 37.13万
  • 项目类别:
Staphylococcus aureus biofilms: in vitro and in vivo studies
金黄色葡萄球菌生物膜:体外和体内研究
  • 批准号:
    7423938
  • 财政年份:
    2007
  • 资助金额:
    $ 37.13万
  • 项目类别:
Staphylococcus aureus biofilms: in vitro and in vivo studies
金黄色葡萄球菌生物膜:体外和体内研究
  • 批准号:
    8074921
  • 财政年份:
    2007
  • 资助金额:
    $ 37.13万
  • 项目类别:

相似海外基金

Rationally guided discovery platform for monoclonal antibodies against carbohydrate antigens using virus-like particle conjugate immunization and high throughput selection
使用病毒样颗粒缀合物免疫和高通量选择的合理引导的针对碳水化合物抗原的单克隆抗体的发现平台
  • 批准号:
    10574738
  • 财政年份:
    2023
  • 资助金额:
    $ 37.13万
  • 项目类别:
Assessing the role of liver stage antigens-specific antibodies against Plasmodium falciparum liver stage infection
评估肝期抗原特异性抗体对抗恶性疟原虫肝期感染的作用
  • 批准号:
    10392870
  • 财政年份:
    2021
  • 资助金额:
    $ 37.13万
  • 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
  • 批准号:
    10092930
  • 财政年份:
    2020
  • 资助金额:
    $ 37.13万
  • 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
  • 批准号:
    9896170
  • 财政年份:
    2020
  • 资助金额:
    $ 37.13万
  • 项目类别:
Interrogation of cell surface antigens on B lineage cells using structurally unique variable lymphocyte receptor antibodies of the evolutionarily distant sea lamprey
使用进化遥远的海七鳃鳗结构独特的可变淋巴细胞受体抗体询问 B 谱系细胞上的细胞表面抗原
  • 批准号:
    433456
  • 财政年份:
    2020
  • 资助金额:
    $ 37.13万
  • 项目类别:
    Operating Grants
Investigations of interactions between various natural antibodies and food-derived antigens
研究各种天然抗体与食物源性抗原之间的相互作用
  • 批准号:
    19K15765
  • 财政年份:
    2019
  • 资助金额:
    $ 37.13万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Identifying Kawasaki Disease-Specific Antibodies and Antigens
识别川崎病特异性抗体和抗原
  • 批准号:
    9932769
  • 财政年份:
    2018
  • 资助金额:
    $ 37.13万
  • 项目类别:
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
  • 批准号:
    BB/P504713/1
  • 财政年份:
    2017
  • 资助金额:
    $ 37.13万
  • 项目类别:
    Training Grant
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
  • 批准号:
    1932904
  • 财政年份:
    2017
  • 资助金额:
    $ 37.13万
  • 项目类别:
    Studentship
SBIR Phase II: Automated Design Methods of Antibodies Directed to Protein and Carbohydrate Antigens
SBIR II 期:针对蛋白质和碳水化合物抗原的抗体的自动化设计方法
  • 批准号:
    1632399
  • 财政年份:
    2016
  • 资助金额:
    $ 37.13万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了